ES2333319T3 - Receptores de la neurotoxina botulinica b y su uso. - Google Patents
Receptores de la neurotoxina botulinica b y su uso. Download PDFInfo
- Publication number
- ES2333319T3 ES2333319T3 ES03816739T ES03816739T ES2333319T3 ES 2333319 T3 ES2333319 T3 ES 2333319T3 ES 03816739 T ES03816739 T ES 03816739T ES 03816739 T ES03816739 T ES 03816739T ES 2333319 T3 ES2333319 T3 ES 2333319T3
- Authority
- ES
- Spain
- Prior art keywords
- syt
- bont
- baselineskip
- binding
- gangliosides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42295102P | 2002-10-31 | 2002-10-31 | |
US422951P | 2002-10-31 | ||
US49812803P | 2003-08-27 | 2003-08-27 | |
US498128P | 2003-08-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2333319T3 true ES2333319T3 (es) | 2010-02-19 |
Family
ID=34197667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES03816739T Expired - Lifetime ES2333319T3 (es) | 2002-10-31 | 2003-10-28 | Receptores de la neurotoxina botulinica b y su uso. |
Country Status (10)
Country | Link |
---|---|
US (2) | US20040191887A1 (ja) |
EP (1) | EP1578382B1 (ja) |
JP (2) | JP2006512090A (ja) |
AT (1) | ATE442161T1 (ja) |
AU (1) | AU2003304419A1 (ja) |
CA (1) | CA2504532C (ja) |
DE (1) | DE60329225D1 (ja) |
ES (1) | ES2333319T3 (ja) |
IL (1) | IL167943A (ja) |
WO (1) | WO2005016233A2 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2333319T3 (es) * | 2002-10-31 | 2010-02-19 | Wisconsin Alumni Research Foundation | Receptores de la neurotoxina botulinica b y su uso. |
US7341843B2 (en) * | 2003-04-11 | 2008-03-11 | Allergan, Inc. | Botulinum toxin A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy |
US8748106B2 (en) * | 2005-04-18 | 2014-06-10 | Bal Ram Singh | Methods of identifying a compound that increases or decreases the interaction of Hn-33 with synaptotagmin II |
DE102005019302A1 (de) | 2005-04-26 | 2006-11-16 | Toxogen Gmbh | Carrier zum Targeting von Nervenzellen |
US7985554B2 (en) * | 2005-10-14 | 2011-07-26 | Wisconsin Alumni Research Foundation | Botulinum neurotoxin A receptor and the use thereof |
DE102005051789B4 (de) | 2005-10-28 | 2014-08-07 | Toxogen Gmbh | Der Botulinus Neurotoxin A Proteinrezeptor und seine Anwendungen |
EP2208067B1 (en) | 2007-09-14 | 2019-02-06 | BioMadison, Inc. | Resonance energy transfer assay with cleavage sequence and spacer |
US11325954B2 (en) | 2011-06-01 | 2022-05-10 | Biomadison, Inc. | Compositions and methods for stability testing of botulinum toxin |
EP2715355B1 (en) | 2011-06-01 | 2017-03-08 | Biomadison, Inc. | Non-fret botulinum assay |
US10908146B2 (en) | 2011-06-01 | 2021-02-02 | Biomadison, Inc. | Compositions and methods for improving sensitivity in cell based assays |
US9303285B2 (en) | 2012-01-04 | 2016-04-05 | Biomadison, Inc. | Methods and compounds for increasing sensitivity of botulinum assays |
ES2818986T5 (es) | 2013-08-09 | 2024-01-25 | Biomadison Inc | Ensayo de toxina botulínica con sensibilidad mejorada |
WO2023210585A1 (ja) * | 2022-04-25 | 2023-11-02 | 株式会社Jiksak Bioengineering | 標的化剤 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6994995B1 (en) * | 2001-03-16 | 2006-02-07 | Lexicon Genetics Incorporated | Human synaptotagmin and polynucleotides encoding the same |
US8022172B2 (en) * | 2001-08-28 | 2011-09-20 | Allergan, Inc. | Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity |
US7176278B2 (en) * | 2001-08-30 | 2007-02-13 | Biorexis Technology, Inc. | Modified transferrin fusion proteins |
ES2333319T3 (es) * | 2002-10-31 | 2010-02-19 | Wisconsin Alumni Research Foundation | Receptores de la neurotoxina botulinica b y su uso. |
EP2502930B1 (en) * | 2003-12-19 | 2016-06-29 | Wisconsin Alumni Research Foundation | Method and compositions for detecting botulinum neurotoxin |
ATE483158T1 (de) * | 2005-04-05 | 2010-10-15 | Allergan Inc | Clostridientoxinaktivitätstests |
ES2426194T3 (es) * | 2005-08-02 | 2013-10-21 | Planet Biotechnology, Inc. | Proteínas quiméricas del receptor de toxina mejoradas y proteínas quiméricas del receptor de toxina para el tratamiento y la prevención de anthrax |
US7985554B2 (en) * | 2005-10-14 | 2011-07-26 | Wisconsin Alumni Research Foundation | Botulinum neurotoxin A receptor and the use thereof |
WO2013011055A1 (en) * | 2011-07-19 | 2013-01-24 | ETH Zürich | Means and methods for determining clostridial neurotoxins |
-
2003
- 2003-10-28 ES ES03816739T patent/ES2333319T3/es not_active Expired - Lifetime
- 2003-10-28 WO PCT/US2003/034348 patent/WO2005016233A2/en active Application Filing
- 2003-10-28 AT AT03816739T patent/ATE442161T1/de not_active IP Right Cessation
- 2003-10-28 DE DE60329225T patent/DE60329225D1/de not_active Expired - Lifetime
- 2003-10-28 CA CA2504532A patent/CA2504532C/en not_active Expired - Fee Related
- 2003-10-28 AU AU2003304419A patent/AU2003304419A1/en not_active Abandoned
- 2003-10-28 EP EP03816739A patent/EP1578382B1/en not_active Expired - Lifetime
- 2003-10-28 JP JP2005507928A patent/JP2006512090A/ja active Pending
- 2003-10-28 US US10/695,577 patent/US20040191887A1/en not_active Abandoned
-
2005
- 2005-04-10 IL IL167943A patent/IL167943A/en unknown
-
2009
- 2009-10-01 JP JP2009229744A patent/JP2010006833A/ja active Pending
-
2011
- 2011-10-26 US US13/281,501 patent/US8617573B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1578382A2 (en) | 2005-09-28 |
DE60329225D1 (de) | 2009-10-22 |
JP2006512090A (ja) | 2006-04-13 |
IL167943A (en) | 2010-12-30 |
US20120082672A1 (en) | 2012-04-05 |
CA2504532C (en) | 2014-09-16 |
JP2010006833A (ja) | 2010-01-14 |
AU2003304419A1 (en) | 2005-03-07 |
EP1578382A4 (en) | 2007-08-29 |
EP1578382B1 (en) | 2009-09-09 |
CA2504532A1 (en) | 2005-02-24 |
US20040191887A1 (en) | 2004-09-30 |
ATE442161T1 (de) | 2009-09-15 |
US8617573B2 (en) | 2013-12-31 |
WO2005016233A3 (en) | 2005-08-18 |
AU2003304419A8 (en) | 2005-03-07 |
WO2005016233A2 (en) | 2005-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8617573B2 (en) | Botulinum neurotoxin B receptors and use thereof | |
Dong et al. | Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells | |
Wilde et al. | The constitutive activity of the adhesion GPCR GPR114/ADGRG5 is mediated by its tethered agonist | |
Rummel et al. | The HCC‐domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction | |
US8450277B2 (en) | Methods for reducing botulinum neurotoxin A toxicity | |
Ando et al. | IRBIT, a novel inositol 1, 4, 5-trisphosphate (IP3) receptor-binding protein, is released from the IP3 receptor upon IP3 binding to the receptor | |
Peng et al. | Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors | |
Liu et al. | Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2 | |
US20140322730A1 (en) | Botulinum Neurotoxin E Receptors and Uses Thereof | |
Zvaritch et al. | A signal for endoplasmic reticulum retention located at the carboxyl terminus of the plasma membrane Ca2+-ATPase isoform 4CI | |
WO2017024204A1 (en) | Engineered enzyme for enzyme replacement therapy | |
Sullivan et al. | PACE-1, a novel protein that interacts with the C-terminal domain of ezrin | |
Yelin et al. | Glycosylation of a vesicular monoamine transporter: a mutation in a conserved proline residue affects the activity, glycosylation, and localization of the transporter | |
US20230126796A1 (en) | Functional and therapeutic effects of par4 cleavage by cathepsin g | |
JP4445291B2 (ja) | 新規タンパク質およびそのdna | |
Rothemund et al. | Lilian M. Demberg1, Jana Winkler1, Caroline Wilde1, Kay-Uwe Simon1, Julia Schön1, Sven | |
US20150268247A1 (en) | Assay for Screening of Anti-Viral Compounds That Inhibit Specific Interaction Interfaces Between Cullin5 and an ElonginB/ElonginC/ CBF-beta/HIV-1 Vif Complex | |
Al Tobi | Consequences of tyrosine phosphorylation of Syntaxin4 and Munc18c on GLUT4 trafficking | |
WO2021225781A2 (en) | Aberrant post-translational modifications (ptms) in methyl- and propionic acidemia and a mutant sirtuin (sirt) to metabolize ptms | |
EP1536011A1 (en) | Preventives/remedies for neurodegenerative diseases | |
Callan | Early events in the biosynthesis of torsinA | |
Oran | Defining sites of interaction in the Ã-chain of C3 for factor H, membrane cofactor protein (MCP), and complement receptor 1 (CR1) | |
CA2461065A1 (en) | Transductin-1 and transductin-2 and applications to hereditary deafness |